Stabilit?? physico-chimique de solutions ophtalmiques renforc??es pr??tes ?? l???emploi??: une revue de la litt??rature, Annales Pharmaceutiques Fran??aises, vol.70, issue.2, pp.2012104-2012116 ,
DOI : 10.1016/j.pharma.2011.11.005
Bonnes pratiques de préparation. JORF, Consulté sur, 2007. ,
Pharmacie galénique: bonnes pratiques de fabrication des médicaments, 2001. ,
Pharmacie galénique: formulation et technologie pharmaceutique, 2012. ,
Das COMOD??-System - Ein konservierungsmittelfreies Mehrdosenbeh??ltnis f??r Augentropfen, Klinische Monatsbl??tter f??r Augenheilkunde, vol.205, issue.10, pp.210-217, 1994. ,
DOI : 10.1055/s-2008-1045518
Moyens d'amélioration de la biodisponibilité pour la voie topique, J Fr Ophtalmol, vol.23, issue.523, pp.505-509, 2000. ,
Stabilit?? ?? ??? 20??C des collyres antibiotiques renforc??s (amikacine, ceftazidime, vancomycine), Journal Fran??ais d'Ophtalmologie, vol.30, issue.8, pp.807-820, 2007. ,
DOI : 10.1016/S0181-5512(07)92614-5
Lacrimal canalicular obstruction associated with topical ocular medication, Australian and New Zealand Journal of Ophthalmology, vol.112, issue.3 ,
DOI : 10.1111/j.1442-9071.1998.tb01315.x
Handbook on injectable drugs, 2011. ,
Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67 ,
Centralized intravenous additive services (CIVAS): the state of the art in, 2010. ,
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations, Journal of Medicinal Chemistry, vol.36, issue.24, pp.3757-64, 1993. ,
DOI : 10.1021/jm00076a002
Estimation of the increase in solubility of drugs as a function of bile salt concentration, Pharmaceutical Research, vol.13, issue.1, pp.163-170, 1996. ,
DOI : 10.1023/A:1016062224568
Pr??paration d???un collyre de ciclosporine ?? 2 %, Journal Fran??ais d'Ophtalmologie, vol.27, issue.6, pp.567-76, 2004. ,
DOI : 10.1016/S0181-5512(04)96181-5
R??tinopathie du pr??matur?? : r??sultats de l???examen du fond d?????il chez 94 enfants ?? risque, Journal Fran??ais d'Ophtalmologie, vol.27, issue.4, pp.337-381, 2004. ,
DOI : 10.1016/S0181-5512(04)96138-4
Les collyres mydriatiques sont-ils dangereux chez le nouveau-né prématuré? Arch Pediatr, pp.299-302, 2011. ,
Prospective assessment of systemic side effects of topical ophthalmic drug administration for screening for retinopathy of prematurity, Paediatric and Perinatal Drug Therapy, vol.7, issue.3, 2006. ,
DOI : 10.1185/146300906X112890
A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study, J Pediatr Ophthalmol Strabismus, vol.29, issue.3, pp.157-62, 1992. ,
Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies, J Pediatr Ophthalmol Strabismus avr, vol.31, issue.2, p.130, 1994. ,
Effects and side effects of mydriatic eyedrops in neonates, Eur J Ophthalmol, vol.6, issue.2, pp.192-198, 1996. ,
Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides, J Pediatr Ophthalmol Strabismus, vol.42, issue.3, pp.166-73, 2005. ,
Pupil dilatation after single and triple doses of mydriatic agent in preterm infants, J Med Assoc Thai nov, vol.92, issue.11, pp.1458-62, 2009. ,
Bromination methods for determination of phenylephrine hydrochloride in nose drops, salicylamide in tablets, and tetracycline hydrochloride in capsules, J Assoc Off Anal Chem. juill, vol.64, issue.4, pp.860-863, 1981. ,
Spectrophotometric determination of phenylephrine HCl and orphenadrine citrate in pure and in dosage forms, Journal of Pharmaceutical and Biomedical Analysis, vol.30, issue.4, pp.1385-92, 2002. ,
DOI : 10.1016/S0731-7085(02)00437-5
Flow-injection determination of phenylephrine hydrochloride in pharmaceutical dosage forms with on-line solid-phase extraction and spectrophotometric detection. Talanta, déc, vol.1564, issue.5, pp.1226-1258, 2004. ,
Quantitative analysis of chlorpheniramine maleate and phenylephrine hydrochloride in nasal drops by differential-derivative spectrophotometric, zero-crossing first derivative UV spectrophotometric and absorbance ratio methods, Journal of Pharmaceutical and Biomedical Analysis, vol.23, issue.6, pp.1023-1054, 2000. ,
DOI : 10.1016/S0731-7085(00)00371-X
High-performance liquid chromatographic determination of phenylephrine and tropicamide in human aqueous humor, Biomedical Chromatography, vol.661, issue.3, pp.202-206, 2000. ,
DOI : 10.1002/1099-0801(200005)14:3<202::AID-BMC943>3.0.CO;2-7
New approaches with two cyano columns to the separation of acetaminophen, phenylephrine, chlorpheniramine and related compounds, Journal of Chromatography B, vol.817, issue.2, pp.159-65, 2005. ,
DOI : 10.1016/j.jchromb.2004.11.060
Drug-excipient compatibility testing???Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold, Journal of Pharmaceutical and Biomedical Analysis, vol.55, issue.5, pp.949-56, 2011. ,
DOI : 10.1016/j.jpba.2011.03.027
Allergic contact blepheroconjunctivitis with phenylephrine eyedrops ???the relevance of late readings of intradermal tests, Allergologia et Immunopathologia, vol.35, issue.4, pp.157-165, 2007. ,
DOI : 10.1157/13108227
Acute hypertension due to phenylephrine eyedrops in a newborn, Canadian Journal of Ophthalmology, vol.42, issue.3, p.486, 2007. ,
DOI : 10.3129/i07-060
Renal failure caused by eyedrops containing phenylephrine in a case of retinopathy of prematurity, J. Med. Invest, vol.50, pp.3-4203, 2003. ,
Le chlorhydrate de phényléphrine activité, étude des produits de dégradation, stabilité selon la nature du conditionnement ,
Handbook on injectable drugs, 2011. ,
EFFECT OF ULTRA-VIOLET IRRADIATION OF PHENYLEPHRINE SOLUTIONS, Journal of Pharmacy and Pharmacology, vol.12, issue.1, pp.538-581, 1963. ,
DOI : 10.1111/j.2042-7158.1963.tb12830.x
The stability of aqueous solutions of phenylephrine at elevated temperatures: identification of the decomposition products, J. Pharm. Pharmacol. déc, vol.25, pp.24-31, 1973. ,
Photochemical hydroxylation of phenylephrine to epinephrine (adrenaline), Journal of Pharmaceutical and Biomedical Analysis, vol.6, issue.5, pp.511-515, 1988. ,
DOI : 10.1016/0731-7085(88)80018-9
Liste des Excipients à Effet Notoire, Consulté sur, 2009. ,
Décision du 12 mars 2010 portant inscription au répertoire des groupes génériques mentionné à l'article R. 5121-5 du code de la santé publique. [cité le 19 juillet 2012]; Consulté sur: ansm ,
Handbook of pharmaceutical excipients. London; Chicago, 2009. ,
Prescrire les collyres fortifi??s, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.423-453, 2007. ,
DOI : 10.1016/S0181-5512(07)89618-5
Caract??ristiques cliniques, microbiologiques et th??rapeutiques d???une s??rie de 111??k??ratites bact??riennes s??v??res, Journal Fran??ais d'Ophtalmologie, vol.34, issue.6, pp.362-370, 2011. ,
DOI : 10.1016/j.jfo.2010.12.003
K??ratites bact??riennes s??v??res et sensibilit?? des germes aux fluoroquinolones, Journal Fran??ais d'Ophtalmologie, vol.32, issue.4, pp.273-279, 2009. ,
DOI : 10.1016/j.jfo.2008.12.002
??tude prospective sur les endophtalmies aigu??s postop??ratoires, Journal Fran??ais d'Ophtalmologie, vol.28, issue.2, pp.135-183, 2005. ,
DOI : 10.1016/S0181-5512(05)81036-8
K??ratites bact??riennes s??v??res: ??tude r??trospective clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.29, issue.8, pp.883-891, 2006. ,
DOI : 10.1016/S0181-5512(06)70108-5
Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases, British Journal of Ophthalmology, vol.87, issue.7, pp.834-842, 2003. ,
DOI : 10.1136/bjo.87.7.834
Collyres et autres topiques antibiotiques dans les infections oculaires superficielles, 2004. ,
Rabbit Streptococcus pneumoniae keratitis model and topical therapy, Invest. Ophthalmol. Vis. Sci. oct, vol.39, issue.11, pp.2012-2019, 1998. ,
Étude de stabilité d'un collyre à 6 mg/mL de ticarcilline. Le Pharmacien Hospitalier et Clinicien, déc, vol.42, issue.171, pp.171-177, 2007. ,
Effect of freezing on stability of a fortified 5 mg/mL ticarcillin ophthalmic solution. Can J Hosp Pham, avr, vol.58, issue.2, pp.65-70, 2005. ,
Determination of ticarcillin levels in serum by high-pressure liquid chromatography., Antimicrobial Agents and Chemotherapy, vol.28, issue.5, pp.597-600, 1985. ,
DOI : 10.1128/AAC.28.5.597
Modification of an ion-paired high pressure liquid chromatography for ticarcillin in human serum, sept, vol.17, issue.5, pp.395-403, 1996. ,
Endophtalmies postop??ratoires ?? Enterococcus faecalis, Journal Fran??ais d'Ophtalmologie, vol.27, issue.3, pp.271-278, 2004. ,
DOI : 10.1016/S0181-5512(04)96130-X
Retinal toxicity of intravitreal ticarcillin. Ophthalmic Surg, pp.563-568, 1990. ,
Fiche de données de sécurité de la ticarcilline. [cité le 12 août 2012, Consulté sur ,
Degradation of penicillin, ticarcillin, and carbenicillin resulting from storage of unit doses, N. Engl. J. Med. 1982 mars, vol.4306, issue.9, pp.547-555 ,
Prescrire les collyres fortifi??s, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.423-453, 2007. ,
DOI : 10.1016/S0181-5512(07)89618-5
Caract??ristiques cliniques, microbiologiques et th??rapeutiques d???une s??rie de 111??k??ratites bact??riennes s??v??res, Journal Fran??ais d'Ophtalmologie, vol.34, issue.6, pp.362-370, 2011. ,
DOI : 10.1016/j.jfo.2010.12.003
K??ratites bact??riennes s??v??res et sensibilit?? des germes aux fluoroquinolones, Journal Fran??ais d'Ophtalmologie, vol.32, issue.4, pp.273-279, 2009. ,
DOI : 10.1016/j.jfo.2008.12.002
??tude prospective sur les endophtalmies aigu??s postop??ratoires, Journal Fran??ais d'Ophtalmologie, vol.28, issue.2, pp.135-183, 2005. ,
DOI : 10.1016/S0181-5512(05)81036-8
K??ratites bact??riennes s??v??res: ??tude r??trospective clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.29, issue.8, pp.883-891, 2006. ,
DOI : 10.1016/S0181-5512(06)70108-5
Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases, British Journal of Ophthalmology, vol.87, issue.7, pp.834-842, 2003. ,
DOI : 10.1136/bjo.87.7.834
Collyres et autres topiques antibiotiques dans les infections oculaires superficielles, 2004. ,
Rabbit Streptococcus pneumoniae keratitis model and topical therapy, Invest. Ophthalmol. Vis. Sci. oct, vol.39, issue.11, pp.2012-2019, 1998. ,
Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67 ,
Prolonged persistence on the ocular surface of fortified gentamicin ointment as compared to fortified gentamicin eye drops, Acta Ophthalmologica Scandinavica, vol.78, issue.1, pp.34-40, 2000. ,
DOI : 10.1034/j.1600-0420.2000.078001034.x
Endophtalmies postop??ratoires ?? Enterococcus faecalis, Journal Fran??ais d'Ophtalmologie, vol.27, issue.3, pp.271-278, 2004. ,
DOI : 10.1016/S0181-5512(04)96130-X
K??ratites bact??riennes s??v??res. ??tude ??pid??miologique, clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.32, issue.8, pp.558-65, 2009. ,
DOI : 10.1016/j.jfo.2009.04.013
Aminoglycoside antibiotics ??? two decades of their hplc bioanalysis, Biomedical Chromatography, vol.231, issue.1, pp.3-10, 1999. ,
DOI : 10.1002/(SICI)1099-0801(199902)13:1<3::AID-BMC811>3.0.CO;2-T
Stability of Extemporaneously Prepared Gentamicin Ophthalmic Solutions, Annals of Pharmacotherapy, vol.27, issue.10, pp.1293-1297, 2001. ,
DOI : 10.1345/aph.19026
Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C, Am J Hosp Pharm, vol.48, issue.3, pp.507-516, 1991. ,
Analysis of underivatized gentamicin by capillary electrophoresis with UV detection, Journal of Pharmaceutical and Biomedical Analysis, vol.44, issue.1, pp.49-56, 2007. ,
DOI : 10.1016/j.jpba.2007.01.029
Bilateral Pseudomonas corneal ulcer in a disposable contact lens wearer, CLAO J. avr, vol.25, issue.2, pp.123-127, 1999. ,
384 K??ratite ?? Nocardia abscessus : ?? propos d???un cas, Journal Fran??ais d'Ophtalmologie, vol.32, issue.0, pp.1-123, 2009. ,
DOI : 10.1016/S0181-5512(09)73508-9
Neisseria meningitidis keratitis in adults: a case series, Ann. Acad. Med. Singap. nov, vol.35, issue.11, pp.837-846, 2006. ,
Acute Renal Failure After Topical Fortified Gentamicin and Vancomycin Eyedrops, Journal of Ocular Pharmacology and Therapeutics, vol.27, issue.4, pp.411-414, 2011. ,
DOI : 10.1089/jop.2010.0163
Handbook on injectable drugs, 2011. ,
Tobramycin and Gentamycin elution analysis between two in situ polymerizable orthopedic composites, Journal of Biomedical Materials Research, vol.4, issue.1, pp.137-186, 2003. ,
DOI : 10.1002/jbm.b.10528
Les conservateurs des collyres??: vers une prise de conscience de leur toxicit??, Journal Fran??ais d'Ophtalmologie, vol.33, issue.7, pp.505-529, 2010. ,
DOI : 10.1016/j.jfo.2010.06.018
Eyelid dermatitis due to sodium metabisulfite. Contact Derm, oct, vol.55, issue.4, pp.249-50, 2006. ,
A Case of Contact Dermatitis Due to Sodium Bisulfite in an Ophthalmic Solution, The Journal of Dermatology, vol.38, issue.10, pp.675-682, 1997. ,
DOI : 10.1111/j.1346-8138.1997.tb02315.x
Control of microbial contamination in unpreserved eyedrops., British Journal of Ophthalmology, vol.80, issue.7, pp.588-91, 1996. ,
DOI : 10.1136/bjo.80.7.588
Effect of Fortified Antibiotic Solutions on Corneal Epithelial Wound Healing, Cornea, vol.19, issue.2, pp.204-210, 2000. ,
DOI : 10.1097/00003226-200003000-00014
Conjunctival Necrosis After Administration of Topical Fortified Aminoglycosides, American Journal of Ophthalmology, vol.111, issue.6, pp.690-693, 1991. ,
DOI : 10.1016/S0002-9394(14)76771-6
Canalicular stenosis due to topical use of fortified antibiotics, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, vol.35, issue.6, pp.334-339, 2000. ,
DOI : 10.1016/S0008-4182(00)80062-9
Handbook of pharmaceutical excipients. London; Chicago, 2009. ,
Comparative Toxicity of Preservatives on Immortalized Corneal and Conjunctival Epithelial Cells, Journal of Ocular Pharmacology and Therapeutics, vol.25, issue.2, pp.113-122, 2009. ,
DOI : 10.1089/jop.2008.0098
Prescrire les collyres fortifi??s, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.423-453, 2007. ,
DOI : 10.1016/S0181-5512(07)89618-5
Caract??ristiques cliniques, microbiologiques et th??rapeutiques d???une s??rie de 111??k??ratites bact??riennes s??v??res, Journal Fran??ais d'Ophtalmologie, vol.34, issue.6, pp.362-370, 2011. ,
DOI : 10.1016/j.jfo.2010.12.003
K??ratites bact??riennes s??v??res et sensibilit?? des germes aux fluoroquinolones, Journal Fran??ais d'Ophtalmologie, vol.32, issue.4, pp.273-279, 2009. ,
DOI : 10.1016/j.jfo.2008.12.002
??tude prospective sur les endophtalmies aigu??s postop??ratoires, Journal Fran??ais d'Ophtalmologie, vol.28, issue.2, pp.135-183, 2005. ,
DOI : 10.1016/S0181-5512(05)81036-8
K??ratites bact??riennes s??v??res: ??tude r??trospective clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.29, issue.8, pp.883-891, 2006. ,
DOI : 10.1016/S0181-5512(06)70108-5
Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases, British Journal of Ophthalmology, vol.87, issue.7, pp.834-842, 2003. ,
DOI : 10.1136/bjo.87.7.834
Collyres et autres topiques antibiotiques dans les infections oculaires superficielles, 2004. ,
Rabbit Streptococcus pneumoniae keratitis model and topical therapy, Invest. Ophthalmol. Vis. Sci. oct, vol.39, issue.11, pp.2012-2019, 1998. ,
Handbook on injectable drugs, 2011. ,
Fiche de données de sécurité de la vancomycine chlorhydrate, Consulté sur ,
Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67 ,
Endophtalmies postop??ratoires ?? Enterococcus faecalis, Journal Fran??ais d'Ophtalmologie, vol.27, issue.3, pp.271-278, 2004. ,
DOI : 10.1016/S0181-5512(04)96130-X
K??ratites bact??riennes s??v??res. ??tude ??pid??miologique, clinique et microbiologique, Journal Fran??ais d'Ophtalmologie, vol.32, issue.8, pp.558-65, 2009. ,
DOI : 10.1016/j.jfo.2009.04.013
Stabilit?? ?? ??? 20??C des collyres antibiotiques renforc??s (amikacine, ceftazidime, vancomycine), Journal Fran??ais d'Ophtalmologie, vol.30, issue.8, pp.807-820, 2007. ,
DOI : 10.1016/S0181-5512(07)92614-5
Pharmaceutical Investigation of Vancomycin Hydrochloride Eye Drops and Their Topical Application to MRSA Eye Infection, YAKUGAKU ZASSHI, vol.121, issue.6, pp.433-442, 2001. ,
DOI : 10.1248/yakushi.121.433
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophthalmic solutions, International Journal of Pharmaceutics, vol.234, issue.1-2, pp.205-217, 20022. ,
DOI : 10.1016/S0378-5173(01)00961-9
Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections, Am J Hosp Pharm juill, vol.43, issue.7, pp.1729-1760, 1986. ,
An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis, Invest. Ophthalmol. Vis. Sci. avr, vol.43, issue.4, pp.1182-1190, 2002. ,
Pasteurella canis and Granulicatella adiacens Conjunctivitis Outbreak Resistant to Empirical Treatment in a Child Welfare Agency, Journal of pediatric ophthalmology and strabismus juill, pp.1-6, 2012. ,
Crystalline keratopathy: an infrequent corneal infection produced by the Streptococcus mitis group, Rev. Argent. Microbiol. sept, vol.43, issue.3, pp.195-202, 2011. ,
Acute Renal Failure After Topical Fortified Gentamicin and Vancomycin Eyedrops, Journal of Ocular Pharmacology and Therapeutics, vol.27, issue.4, pp.411-414, 2011. ,
DOI : 10.1089/jop.2010.0163
Ocular Hypersensitivitiy to Topical Vancomycin in a Case of Chronic Endophthalmitis, Cornea, vol.24, issue.6, pp.754-760, 2005. ,
DOI : 10.1097/01.ico.0000154386.43732.b5
Use of vancomycin in vitrectomy infusion solution and evaluation of retinal toxicity, International Ophthalmology, vol.66, issue.2, pp.85-93, 1993. ,
DOI : 10.1007/BF00942780
Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin, British Journal of Ophthalmology, vol.88, issue.1, pp.22-26, 2004. ,
DOI : 10.1136/bjo.88.1.22
Structure Studies on Vancomycin, Journal of Medicinal Chemistry, vol.8, issue.1, pp.18-22, 1965. ,
DOI : 10.1021/jm00325a004
Etude de stabilité d'un collyre à la vancomycine à 50mg/mL, J Pharm Clin, vol.18, issue.2, pp.183-192, 1999. ,
In Vitro Stability of Fortified Ophthalmic Antibiotics Stored at ???20??C for 6 Months, Cornea, vol.29, issue.7, pp.807-818, 2010. ,
DOI : 10.1097/ICO.0b013e3181c32573
Stability of vancomycin in plastic syringes measured by high???performance liquid chromatography, Journal of Clinical Pharmacy and Therapeutics, vol.4, issue.5, pp.319-344, 1995. ,
DOI : 10.1021/jm00325a004
Prescrire les collyres antifongiques et antiamibiens, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.431-436, 2007. ,
DOI : 10.1016/S0181-5512(07)89619-7
Keratomycosis: diagnosis and therapy, Der Ophthalmologe, vol.776, issue.5, pp.471-480, 2009. ,
DOI : 10.1007/s00347-009-1925-1
K??ratites fongiques, Journal Fran??ais d'Ophtalmologie, vol.34, issue.8, pp.563-570, 2011. ,
DOI : 10.1016/j.jfo.2011.03.001
Kératites fongiques au Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts: étude rétrospective sur 19 cas, J Fr Ophtalmol nov, vol.25, issue.9, pp.890-896, 2002. ,
Spectrum of Fungal Keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania, Cornea, vol.19, issue.3, pp.307-319, 2000. ,
DOI : 10.1097/00003226-200005000-00010
Comparative Toxicity and Concentrations of Intravitreal Amphotericin B Formulations in a Rabbit Model, Investigative Opthalmology & Visual Science, vol.44, issue.5 ,
DOI : 10.1167/iovs.02-1020
Liposomal amphotericin B eye drops to treat fungal keratitis: Physico-chemical and formulation stability, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.150-153, 2007. ,
DOI : 10.1016/j.ijpharm.2007.04.028
Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67 ,
Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.760, issue.2 ,
DOI : 10.1016/S0378-4347(01)00292-4
A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit, oct, vol.18, issue.5, pp.604-613, 1996. ,
High-Performance Liquid Chromatographic Determination of Amphotericin B in a Liposomal Pharmaceutical Product and Validation of the Assay, Journal of Chromatographic Science, vol.38, issue.8, pp.338-382, 2000. ,
DOI : 10.1093/chromsci/38.8.338
Efficacit?? de l???amphot??ricine??B liposomale dans le traitement d???une k??ratite ?? Fusarium solani r??sistante, Journal Fran??ais d'Ophtalmologie, vol.32, issue.10, pp.721-727, 2009. ,
DOI : 10.1016/j.jfo.2009.10.011
Treatment of Postkeratitis Fusarium Endophthalmitis with Amphotericin B Lipid Complex, Cornea, vol.19, issue.6, pp.853-859, 2000. ,
DOI : 10.1097/00003226-200011000-00019
Unilateral Candida parapsilosis Interface Keratitis After Laser In Situ Keratomileusis-Case Report and Review of the Literature, Cornea, vol.28, issue.1, pp.105-112, 2009. ,
DOI : 10.1097/ICO.0b013e318184e69b
Infectious keratitis in patients undergoing Boston Type 1 keratoprosthesis (Boston KPro) procedure: case series, Arquivos Brasileiros de Oftalmologia, vol.74, issue.2, pp.127-136, 2011. ,
DOI : 10.1590/S0004-27492011000200012
Treatment of Keratomycosis with Amphotericin B 0.15%, American Journal of Ophthalmology, vol.81, issue.6, pp.847-856, 1976. ,
DOI : 10.1016/0002-9394(76)90369-X
Mycotic keratitis in South Florida: a review of thirty-nine cases, Trans Ophthalmol Soc U K, vol.89, pp.781-97, 1970. ,
Mycokeratitis: Treatment of Fungal Corneal Ulcers with Amphotericin B and Mechanical Debridement, Southern Medical Journal, vol.56, issue.3, pp.270-274, 1963. ,
DOI : 10.1097/00007611-196303000-00008
Ocular Penetration of Amphotericin B, Archives of Ophthalmology, vol.73, issue.6, pp.769-75, 1965. ,
DOI : 10.1001/archopht.1965.00970030771004
Novel modes of antifungal drug administration, Expert Opinion on Investigational Drugs, vol.403, issue.7, pp.903-935, 2004. ,
DOI : 10.1016/S0883-5403(98)90086-9
Fungal keratitis caused by Scopulariopsis brevicaulis: successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement., British Journal of Ophthalmology, vol.78, issue.9, p.730, 1994. ,
DOI : 10.1136/bjo.78.9.730
Rhinosporidiosis and peripheral keratitis, Ophthalmic Surg Lasers, vol.32, issue.4, pp.338-378, 2001. ,
Topical Amphotericin B and Subconjunctival Injection of Fluconazole (Combination Therapy) Versus Topical Amphotericin B (Monotherapy) in Treatment of Keratomycosis, Journal of Ocular Pharmacology and Therapeutics, vol.26, issue.3, pp.281-286, 2010. ,
DOI : 10.1089/jop.2010.0005
Applications of Liposomes in Ophthalmology, Survey of Ophthalmology, vol.50, issue.2, pp.167-82, 2005. ,
DOI : 10.1016/j.survophthal.2004.12.006
Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B]. Ophthalmologe, pp.469-75, 1995. ,
Handbook on injectable drugs, 2011. ,
Centralized intravenous additive services (CIVAS): The state of the art in 2010, Annales Pharmaceutiques Fran??aises, vol.69, issue.1, pp.30-37, 2011. ,
DOI : 10.1016/j.pharma.2010.09.002
Handbook of pharmaceutical excipients. London; Chicago, 2009. ,
Fiche de données de sécurité de l'amphotéricine B. [cité le 18 juill, Consulté sur, 2012. ,
Monographie sur la stabilité de l'amphotéricine B liposomale, Consulté sur ,
Prise en charge clinique et pronostic des kératites amibiennes: etude rétrospective à propos de 25 cas, J Fr Ophtalmol déc, vol.25, issue.10, pp.1007-1020, 2002. ,
Acanthamoeba Keratitis, Survey of Ophthalmology, vol.42, issue.6, pp.493-508, 1998. ,
DOI : 10.1016/S0039-6257(98)00004-6
Infections cornéennes: diagnostic et traitement, 2004. ,
Primary amebic meningoencephalitis in a healthy 7-year-old boy, The Journal of Pediatrics, vol.85, issue.1, pp.131-137, 1974. ,
DOI : 10.1016/S0022-3476(74)80309-4
Traitement de la kératite amibienne: étude de cas cliniques observés au CHU de Nancy, J Pharm Clin, vol.28, issue.1, pp.27-32, 2009. ,
Prescrire les collyres antifongiques et antiamibiens, Journal Fran??ais d'Ophtalmologie, vol.30, issue.4, pp.431-436, 2007. ,
DOI : 10.1016/S0181-5512(07)89619-7
Acanthamoeba keratitis update???incidence, molecular epidemiology and new drugs for treatment, Eye, vol.17, issue.8, pp.893-905, 2003. ,
DOI : 10.1038/sj.eye.6700563
Préparations hospitalières ophtalmiques: fabrications et utilisations thérapeutiques, pp.5-67 ,
A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis, Invest. Ophthalmol. Vis. Sci, vol.35, issue.3, pp.1059-64, 1994. ,
Amebicide activity of antiseptics and an antibiotic on 2 Acanthamoeba isolated from corneal ulcers], J Fr Ophtalmol oct, vol.21, issue.8, pp.577-82, 1998. ,
Amibes et lentilles cornéennes, Consulté sur, 2012. ,
Successful medical treatment of Acanthamoeba keratitis, International Ophthalmology, vol.21, issue.4, pp.223-230, 19971998. ,
DOI : 10.1023/A:1006055918101
Acanthamoeba Keratitis: Diagnosis and Treatment Update 2009, American Journal of Ophthalmology, vol.148, issue.4, pp.487-499, 2009. ,
DOI : 10.1016/j.ajo.2009.06.009
A review of 72 consecutive cases of Acanthamoeba keratitis, 1984???1992, Eye, vol.34, issue.6, pp.719-744, 1984. ,
DOI : 10.1007/BF00927262
Treatment of Acanthamoeba Keratitis with Polyhexamethylene Biguanide, Ophthalmology, vol.99, issue.2, pp.185-91, 1992. ,
DOI : 10.1016/S0161-6420(92)31994-3
Comparison of Polyhexamethylene Biguanide and Chlorhexidine as Monotherapy Agents in the Treatment of Acanthamoeba Keratitis, American Journal of Ophthalmology, vol.145, issue.1, pp.130-135, 2008. ,
DOI : 10.1016/j.ajo.2007.08.040
Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine, Eye, vol.8, issue.95, pp.413-434, 1996. ,
DOI : 10.1016/0035-9203(95)90429-8
Kératites amibiennes: rôles du pharmacien d'officine et du pharmacien hospitalier dans la prévention et le traitement, J Pharm Clin sept, vol.30, issue.3, pp.129-164, 2011. ,
Kératite à Acanthamoeba chez les porteurs de lentilles de contact: discussion et traitement. Pharmakon, janv, vol.35, issue.1, pp.10-13, 2003. ,
Analysis of polyhexamethylene biguanide in multipurpose contact lens solutions???, Talanta, vol.80, issue.2, pp.1016-1025, 2009. ,
DOI : 10.1016/j.talanta.2009.07.031
Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba, Clinical and Experimental Ophthalmology, vol.27, issue.2, pp.119-143, 2000. ,
DOI : 10.1145/256157.256160
Chemotherapy for acanthamoeba keratitis. Lancet. 1995 mars 25, pp.791-792 ,
Handbook of pharmaceutical excipients. London; Chicago, 2009. ,